In vitro PHOTOSENSITIZING PROPERTIES OF RHODAMINE 123 ON DIFFERENT HUMAN TUMOR CELL LINES

— In this study, human tumor cell lines of different origin (colon carcinoma HT29, breast carcinoma MCF7 and malignant melanoma M14) were incubated for 24 h at 37*deg;C with Rhodamine 123 (Rh123) at concentrations ranging up to 4 μg/ml;. Immediately after drug removal, light irradiation was delivered at 500 W/m2 for 5 min using an argon laser. After irradiation, viable cells were counted and assayed for colony formation. When only Rh123 was administered, a 50% survival was obtained at about 2.77 μg/ml and 1.48 μg/ml; for HT29 and MCF7, respectively. After light irradiation, 50% survival doses decreased to 0.47 μg/ml and 0.18 μg/ml for the two carcinoma cell lines, respectively. In the case of malignant melanoma, the decrease in survival was relatively lower than those obtained with carcinoma cells: 50% survival dose was 3.54 μg/ml with Rh123 alone and 1.32 μ/ml after irradiation. The lower sensitivity of M14 melanoma cells seems to be related to different uptake and release of drug by these cells with respect to carcinoma lines.